SV Health Investors

SV Health Investors is a specialist healthcare fund manager founded in 1993, investing across multiple stages, geographic regions, and sectors with expertise spanning biotechnology, dementia, medical devices, healthcare growth, and healthcare technology. The firm manages dedicated funds across three core verticals — Therapeutics Funds (funding early- to late-stage biotechnology companies developing precision medicines, including SV Biotech and SV Dementia Funds), a Growth Fund (accelerating growth-stage healthcare services, medical products, and digital health companies), and the Medtech Convergence Fund (specializing in novel medical device and remote-monitoring technologies). SV employs a company creation approach to biotech investing, backing inspiring and talented innovators with diverse experiences to create healthcare industry leaders that attract strategic acquirers and public investors. Since its founding, SV has invested in, created, and built more than 200 companies, resulting in the licensing of 24 novel drugs and six new drug classes, while strongly adhering to the view that diversity, including under-represented groups, strongly adds to success.